Novo Nordisk shares tumble 11% after company forecasts sales declines this year

CNBC Published Updated Stocks
Sign in to save

Affected assets and topics

SHARES MARKET

Why it matters

Novo Nordisk's shares plummeted 11% after the company predicted sales declines this year, despite relying on its new weight loss products to regain market share in the US.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bearish Confidence 90% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on bearish sentiment with 90% confidence.

Evidence trail

Evidence
Source CNBC
Claim Novo Nordisk shares tumble 11% after company forecasts sales declines this year
AI inference Bearish · 90%
Generated 2026-02-03 17:06

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
40997

Original source

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.

Read the full article on CNBC

Original article published by CNBC on February 3, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage